Literature DB >> 20830407

Highly stable and soluble bis-aqua Gd, Nd, Yb complexes as potential bimodal MRI/NIR imaging agents.

Gaylord Tallec1, Daniel Imbert, Pascal H Fries, Marinella Mazzanti.   

Abstract

A tripodal ligand based on the 8-hydroxyquinolinate binding unit yields a soluble and highly stable bis-hydrated Gd(3+) complex in water (pGd = 19.2(3)) with relaxivity change in the pH range 4.5-7.4 and Nd(3+), Yb(3+) analogues with sizeable NIR emission upon excitation at 370 nm providing a new architecture for the development of bimodal agents.

Entities:  

Year:  2010        PMID: 20830407     DOI: 10.1039/c0dt00994f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

1.  Optimizing sensitization processes in dinuclear luminescent lanthanide oligomers: selection of rigid aromatic spacers.

Authors:  Jean-François Lemonnier; Laure Guénée; César Beuchat; Tomasz A Wesolowski; Prasun Mukherjee; David H Waldeck; Kristy A Gogick; Stéphane Petoud; Claude Piguet
Journal:  J Am Chem Soc       Date:  2011-09-20       Impact factor: 15.419

2.  An interplay between infrared multiphoton dissociation Fourier-transform ion cyclotron resonance mass spectrometry and density functional theory computations in the characterization of a tripodal quinolin-8-olate Gd(III) complex.

Authors:  Margherita De Bonis; Giuliana Bianco; Mario Amati; Sandra Belviso; Tommaso R I Cataldi; Francesco Lelj
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-23       Impact factor: 3.109

3.  Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.

Authors:  Christopher M Andolina; Piper J Klemm; William C Floyd; Jean M J Fréchet; Kenneth N Raymond
Journal:  Macromolecules       Date:  2012-11-12       Impact factor: 5.985

4.  Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

Authors:  Eszter Boros; Miloslav Polasek; Zhaoda Zhang; Peter Caravan
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.